Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine whether the addition of oral ixazomib to the background therapy of lenalidomide and dexamethasone improves progression-free survival (PFS) in patients with relapsed and/or refractory multiple myeloma (RRMM)
Critère d'inclusion
- Relapsed and/or Refractory Multiple Myeloma